1. The multidimensional value of natriuretic peptides in heart failure, integrating laboratory and clinical aspects.
- Author
-
Gruson, Damien, Hammerer-Lercher, Angelika, Collinson, Paul, Duff, Christopher, Baum, Hannsjörg, Pulkki, Kari, Suvisaari, Janne, Stankovic, Sanja, Laitinen, Paivi, and Bayes-Genis, Antoni
- Subjects
HEART failure risk factors ,RISK assessment ,PATIENT education ,SELF-efficacy ,HEART failure ,PEPTIDE hormones ,EARLY diagnosis ,DYSPNEA ,NATRIURETIC peptides ,BIOMARKERS ,SYMPTOMS - Abstract
Natriuretic peptides (NP) play an essential role in heart failure (HF) regulation, and their measurement has improved diagnostic and prognostic accuracy. Clinical symptoms and objective measurements, such as NP levels, should be included in the HF definition to render it more reliable and consistent among observers, hospitals, and healthcare systems. BNP and NT-proBNP are reasonable surrogates for cardiac disease, and their measurement is critical to early diagnosis and risk stratification of HF patients. NPs should be measured in all patients presenting with dyspnea or other symptoms suggestive of HF to facilitate early diagnosis and risk stratification. Both BNP and NT-proBNP are currently used for guided HF management and display comparable diagnostic and prognostic accuracy. Standardized cutoffs for each NP assay are essential for data comparison. The value of NP testing is recognized at various levels, including patient empowerment and education, analytical and operational issues, clinical HF management, and cost-effectiveness. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF